标题
Insulin therapy development beyond 100 years
作者
关键词
-
出版物
Lancet Diabetes & Endocrinology
Volume 9, Issue 10, Pages 695-707
出版商
Elsevier BV
发表日期
2021-09-02
DOI
10.1016/s2213-8587(21)00182-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Glycaemic efficacy and safety of mealtime faster‐acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus: A meta‐analysis of randomized controlled trials
- (2021) Rimesh Pal et al. DIABETIC MEDICINE
- A global perspective on the issue of access to insulin
- (2021) David Beran et al. DIABETOLOGIA
- New closed-loop insulin systems
- (2021) Charlotte K. Boughton et al. DIABETOLOGIA
- ‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues
- (2021) Mark A. Jarosinski et al. DIABETOLOGIA
- Advances in Subcutaneous Delivery Systems of Biomacromolecular Agents for Diabetes Treatment
- (2021) Chen Li et al. International Journal of Nanomedicine
- Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
- (2021) Rune V. Overgaard et al. CLINICAL PHARMACOKINETICS
- Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
- (2021) Harpreet S. Bajaj et al. DIABETES CARE
- A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100
- (2021) Ildiko Lingvay et al. DIABETES CARE
- The evolution of insulin therapy
- (2021) Philip Home DIABETES RESEARCH AND CLINICAL PRACTICE
- The current schemes of insulin therapy: Pro and contra
- (2021) Matthew C. Riddle DIABETES RESEARCH AND CLINICAL PRACTICE
- Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans
- (2021) Thomas B. Kjeldsen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering
- (2021) Nicole A J Krentz et al. Lancet Diabetes & Endocrinology
- The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications
- (2020) David R. Owens et al. DIABETES OBESITY & METABOLISM
- Recent advances in the chemical synthesis of insulin and related peptides
- (2020) Florence M Brunel et al. Future Medicinal Chemistry
- Recent progress in design and preparation of glucose-responsive insulin delivery systems
- (2020) Di Shen et al. JOURNAL OF CONTROLLED RELEASE
- 1004-P: Oral Insulin (ORMD-0801) Effects on Glucose Parameters in Uncontrolled T2DM on OADs
- (2020) ROY ELDOR et al. DIABETES
- 105-LB: Evening Oral Insulin (ORMD-0801) Glycemic Effects in Uncontrolled T2DM Patients
- (2020) ROY ELDOR et al. DIABETES
- 237-OR: Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes
- (2020) ULRIKE HÖVELMANN et al. DIABETES
- Smarter Modeling to Enable a Smarter Insulin
- (2020) Simeon I. Taylor et al. DIABETES
- Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial
- (2020) Julio Rosenstock et al. DIABETES CARE
- Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study
- (2020) Leslie Klaff et al. DIABETES OBESITY & METABOLISM
- An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients
- (2020) Joseph L. Mann et al. Science Translational Medicine
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
- (2020) Emma Barron et al. Lancet Diabetes & Endocrinology
- Selection of Small Molecules that Bind to and Activate the Insulin Receptor from a DNA-Encoded Library of Natural Products
- (2020) Jia Xie et al. iScience
- Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
- (2020) Julio Rosenstock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review: Glucose-sensitive insulin
- (2020) Thomas Hoeg-Jensen Molecular Metabolism
- Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
- (2019) Inge B Halberg et al. Lancet Diabetes & Endocrinology
- An ingestible self-orienting system for oral delivery of macromolecules
- (2019) Alex Abramson et al. SCIENCE
- Better glycemic control with BioChaperone Combo (BC Combo) than with insulin lispro Mix25 (LMix) or separate glargine & lispro (G+L) administrations after a test meal in subjects with type 2 diabetes (T2DM)
- (2019) Grégory Meiffren et al. DIABETES OBESITY & METABOLISM
- 1086-P: Preclinical Development of an Ultralong-Acting Insulin for Once-Weekly Dosing
- (2019) VICTOR G. HOWARD et al. DIABETES
- Nanoscale cationic micelles of amphiphilic copolymers based on star-shaped PLGA and PEI cross-linked PEG for protein delivery application
- (2019) Jun Wang et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus
- (2019) Anand Khedkar et al. Clinical Pharmacology in Drug Development
- Total Chemical Synthesis of a Nonfibrillating Human Glycoinsulin
- (2019) Mohammed Akhter Hossain et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Long-lasting Insulin Treatment Via a Single Subcutaneous Administration of Liposomes in Thermoreversible Pluronic® F127 Based Hydrogel
- (2018) Xiaoyu Chen et al. CURRENT PHARMACEUTICAL DESIGN
- Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts
- (2018) Mary Courtney Moore et al. DIABETES
- Microneedles as Enhancer of Drug Absorption Through the Skin and Applications in Medicine and Cosmetology
- (2018) Pablo Serrano-Castañeda et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Adapting liposomes for oral drug delivery
- (2018) Haisheng He et al. Acta Pharmaceutica Sinica B
- Clinical Evaluation of MK-2640: An Insulin Analog with Glucose-Responsive Properties
- (2018) Alexander W. Krug et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of Insulin Tregopil and its Permeation Enhancer on Pharmacokinetics of Metformin in Healthy Volunteers: Randomized, Open-label, Placebo Controlled, Crossover Study
- (2018) Anand Khedkar et al. CTS-Clinical and Translational Science
- BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study
- (2018) Tim Heise et al. DIABETES OBESITY & METABOLISM
- Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions
- (2018) Michael R Rickels et al. ENDOCRINE REVIEWS
- The challenge of modulating β-cell autoimmunity in type 1 diabetes
- (2018) Mark A Atkinson et al. Lancet Diabetes & Endocrinology
- Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3
- (2016) R. M. Bergenstal et al. DIABETES OBESITY & METABOLISM
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
- (2016) Richard M. Bergenstal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Insulin Mimetic Peptide Disrupts the Primary Binding Site of the Insulin Receptor
- (2016) Callum F. Lawrence et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insulin/receptor binding: The last piece of the puzzle?
- (2015) Pierre De Meyts BIOESSAYS
- Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes
- (2015) Christopher J. Nolan et al. DIABETES
- Trends in Insulin Use and Diabetes Control in the U.S.: 1988–1994 and 1999–2012
- (2015) Elizabeth Selvin et al. DIABETES CARE
- Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis
- (2015) Rachel R Huxley et al. Lancet Diabetes & Endocrinology
- Identification of novel insulin mimetic drugs by quantitative total internal reflection fluorescence (TIRF) microscopy
- (2014) Peter Lanzerstorfer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Intestinal absorption of insulin nanoparticles: Contribution of M cells
- (2014) Marlene Almeida Lopes et al. Nanomedicine-Nanotechnology Biology and Medicine
- Insulin Receptor Signaling in Normal and Insulin-Resistant States
- (2014) J. Boucher et al. Cold Spring Harbor Perspectives in Biology
- Hepatoselectivity and the evolution of insulin
- (2013) R. Herring et al. DIABETES OBESITY & METABOLISM
- Biotinylated liposomes as potential carriers for the oral delivery of insulin
- (2013) Xingwang Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- How insulin engages its primary binding site on the insulin receptor
- (2013) John G. Menting et al. NATURE
- Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study
- (2013) Roy Eldor et al. PLoS One
- Engineering of Insulin Receptor Isoform-Selective Insulin Analogues
- (2011) Tine Glendorf et al. PLoS One
- A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects
- (2010) A. Khedkar et al. DIABETES OBESITY & METABOLISM
- Oral insulin - a review of current status
- (2009) Harish Iyer et al. DIABETES OBESITY & METABOLISM
- Glucose sensors: a review of current and emerging technology
- (2008) N. S. Oliver et al. DIABETIC MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started